Appointment booking for Dr. Michael Frand, MD is currently not available.Dr. Michael Frand, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Michael Frand, MD (he/him) is a Pediatrician in Littleton, CO with over 18 years of experience. What is your opinion of Dr. Michael Frand, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Michael Frand, MD has received over $1,551 which includes payments from the following companies:
$309.09 from Shire North American Group Inc
$176.68 from Merck Sharp & Dohme Corporation
$153.59 from Pfizer Inc.
$152.01 from Mylan Specialty L.P.
$102.33 from Sanofi Pasteur Inc.
$82.64 from MedImmune, LLC
$74.23 from Ironshore Pharmaceuticals Inc.
$63.71 from GlaxoSmithKline, LLC.
$62.79 from Tris Pharma Inc
$58.50 from Vertical Pharmaceuticals, LLC
$46.83 from AstraZeneca Pharmaceuticals LP
$31.60 from Kaleo, Inc.
$30.70 from Neos Therapeutics, LP
$27.59 from Phadia US Inc.
$26.82 from Alexion Pharmaceuticals, Inc.
$21.37 from Galderma Laboratories, L.P.
$20.82 from Meda Pharmaceuticals, Inc.
$17.90 from Sunovion Pharmaceuticals Inc.
$17.18 from HOLOGIC INC
$16.96 from sanofi-aventis U.S. LLC
Payments received by Dr. Michael Frand, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!